F. Hoffmann-La Roche Ltd (ROG) - Financial and Strategic SWOT Analysis Review

Date: April 5, 2017
Pages: 84
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: F012BF3B0A5EN
Leaflet:

Download PDF Leaflet

F. Hoffmann-La Roche Ltd (ROG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

F. Hoffmann-La Roche Ltd (Roche) develops drugs that improve the standard of care across major disease areas. It provides pharmaceuticals in cancer, neuroscience, infection, immunology, ophthalmology, cardiovascular and metabolism, immunology, hematology, hemophilia and respiratory disease areas. The company also provides in vitro diagnostics, tissue-based cancer diagnostics, as well as diabetes management solutions. Roche’s diagnostic products include clinical chemistry and immunoassays, molecular diagnostics, tissue diagnostics, point of care diagnostics, laboratory automation and IT solutions, urinalysis products, lab testing products, custom biotech solutions, patient self-testing products and solutions for life science. The company offers its products and services to hospitals, commercial diagnostic laboratories, healthcare professionals, researchers and pharmacists. Roche is headquartered in Basel, Switzerland.

F. Hoffmann-La Roche Ltd Key Recent Developments

Feb 01,2017: Roche reports good results in 2016
Dec 05,2016: Changes in Roche Board of Directors
Nov 21,2016: Roche launches DISCOVERY 5-Plex procedure for cancer research applications
Nov 14,2016: Roche launches imCORE, a global network of cancer immunotherapy centers of excellence
Nov 07,2016: Roche launches new RNA HyperPrep product line

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

F. Hoffmann-La Roche Ltd - Key Facts
F. Hoffmann-La Roche Ltd - Key Employees
F. Hoffmann-La Roche Ltd - Key Employee Biographies
F. Hoffmann-La Roche Ltd - Major Products and Services
F. Hoffmann-La Roche Ltd - Pharmaceutical Pipeline Products Data
F. Hoffmann-La Roche Ltd, Pipeline Products by Therapy Area
F. Hoffmann-La Roche Ltd, Pipeline Products by Development Phase
F. Hoffmann-La Roche Ltd - History
F. Hoffmann-La Roche Ltd - Company Statement
F. Hoffmann-La Roche Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

F. Hoffmann-La Roche Ltd - Business Description
Business Description - Diagnostics
Diagnostics - Overview
Diagnostics - Financials
Business Description - Pharmaceuticals
Pharmaceuticals - Overview
Pharmaceuticals - Financials
F. Hoffmann-La Roche Ltd - Corporate Strategy
F. Hoffmann-La Roche Ltd - SWOT Analysis
SWOT Analysis - Overview
F. Hoffmann-La Roche Ltd - Strengths
F. Hoffmann-La Roche Ltd - Weaknesses
F. Hoffmann-La Roche Ltd - Opportunities
F. Hoffmann-La Roche Ltd - Threats
F. Hoffmann-La Roche Ltd - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

F. Hoffmann-La Roche Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
F. Hoffmann-La Roche Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
F. Hoffmann-La Roche Ltd, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Feb 01, 2017: Roche reports good results in 2016
Dec 05, 2016: Changes in Roche Board of Directors
Nov 21, 2016: Roche launches DISCOVERY 5-Plex procedure for cancer research applications
Nov 14, 2016: Roche launches imCORE, a global network of cancer immunotherapy centers of excellence
Nov 07, 2016: Roche launches new RNA HyperPrep product line
Oct 20, 2016: Roche delivers good sales growth in the first nine months of 2016
Aug 02, 2016: Roche introduces virtual reality theater at AACC 2016 Clinical Lab Expo to give lab professionals firsthand glimpse of connected lab of the future
Aug 02, 2016: Roche launches new target enrichment systems for genetic and translational research
Jul 29, 2016: Roche comments on new Cancer Drugs Fund
Jul 21, 2016: Roche delivers continued growth in the first half of 2016

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

F. Hoffmann-La Roche Ltd, Key Facts
F. Hoffmann-La Roche Ltd, Key Employees
F. Hoffmann-La Roche Ltd, Key Employee Biographies
F. Hoffmann-La Roche Ltd, Major Products and Services
F. Hoffmann-La Roche Ltd, Number of Pipeline Products by Therapy Area
F. Hoffmann-La Roche Ltd, Number of Pipeline Products by Therapy Area (Cont.1)
F. Hoffmann-La Roche Ltd, Number of Pipeline Products by Development Stage
F. Hoffmann-La Roche Ltd, History
F. Hoffmann-La Roche Ltd, Subsidiaries
F. Hoffmann-La Roche Ltd, Key Competitors
F. Hoffmann-La Roche Ltd, Ratios based on current share price
F. Hoffmann-La Roche Ltd, Annual Ratios
F. Hoffmann-La Roche Ltd, Annual Ratios (Cont.1)
F. Hoffmann-La Roche Ltd, Interim Ratios
F. Hoffmann-La Roche Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
F. Hoffmann-La Roche Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
F. Hoffmann-La Roche Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

F. Hoffmann-La Roche Ltd, Pipeline Products by Therapy Area
F. Hoffmann-La Roche Ltd, Pipeline Products by Development Phase
F. Hoffmann-La Roche Ltd, Performance Chart (2012 - 2016)
F. Hoffmann-La Roche Ltd, Ratio Charts
F. Hoffmann-La Roche Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
F. Hoffmann-La Roche Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017

COMPANIES MENTIONED

Zentiva SA
Takeda Pharmaceutical Company Ltd
Sanofi
Pfizer Inc
Novartis AG
Merck & Co Inc
Johnson & Johnson
GTx Inc
GlaxoSmithKline Plc
Eli Lilly and Company
Danish Pain Research Center
Bristol-Myers Squibb Company
BioThema AB
Becton Dickinson and Co
Bayer AG
AstraZeneca Plc
Astellas Pharma Inc
Amgen Inc
Abbott Laboratories
Abaxis Inc
Skip to top


Ask Your Question

F. Hoffmann-La Roche Ltd (ROG) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: